SkinBioTherapeutics (LON:SBTX) Shares Down 1.8% – Here’s Why

SkinBioTherapeutics plc (LON:SBTX) shares traded down 1.8% during mid-day trading on Friday . The stock traded as low as GBX 13.25 ($0.17) and last traded at GBX 13.50 ($0.17). 349,729 shares traded hands during mid-day trading, a decline of 63% from the average session volume of 956,980 shares. The stock had previously closed at GBX 13.75 ($0.17).

SkinBioTherapeutics Trading Down 1.8 %

The firm has a 50-day moving average of GBX 13.09 and a two-hundred day moving average of GBX 11.46. The firm has a market capitalization of £30.52 million, a P/E ratio of -675.00 and a beta of 2.01. The company has a current ratio of 6.57, a quick ratio of 10.01 and a debt-to-equity ratio of 2.66.

SkinBioTherapeutics Company Profile

SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe. It develops SkinBiotix technology that promotes skin health by harnessing the beneficial properties of probiotic bacteria and the active components; and AxisBiotix technology that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis.